J0225 HCPCS code: Injection, vutrisiran, 1 mg
J0225 is the HCPCS Level II code for injection, vutrisiran, 1 mg. In 2024 Medicare paid an average of $3,760.27 per service for J0225 across 21,002 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 25 per day on DME suppliers. Medicare volume rose 21% from 2023 to 2024 (17,415 to 21,002 services). In 2024, about 274 clinicians billed Medicare for J0225 for 285 beneficiaries; New York, Texas, Florida accounted for 58% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2023-01-01 |
| Last action effective | 2023-01-01 |
Who bills J0225 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 274 |
| Medicare beneficiaries | 285 |
| States with claims | 10 |
| Share of services in top 3 states (New York, Texas, Florida) | 58% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0225, 2023–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2023 | 17,415 | 236 | $4,694.96 | $3,740.54 |
| 2024 | 21,002 | 285 | $4,719.96 | $3,760.27 |
States with the most J0225 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| New York | 4,046 | $3,462.24 |
| Texas | 2,450 | $3,867.89 |
| Florida | 2,069 | $3,869.04 |
| Maryland | 1,212 | $3,836.05 |
| California | 1,055 | $3,855.32 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| DME suppliers | 25 | Prescribing Information |
| outpatient hospital claims | 25 | Prescribing Information |
| practitioner claims | 25 | Prescribing Information |
What changed for J0225
- 2023-01-01: J0225 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0225?
J0225 is the HCPCS Level II code for injection, vutrisiran, 1 mg. Short descriptor: "Inj, vutrisiran, 1 mg".
How much does Medicare pay for J0225?
In 2024, the average Medicare payment was $3,760.27 per service (average allowed $4,719.96).
Does Medicare cover J0225?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J0225 can be billed per day?
25 on DME suppliers; 25 on outpatient hospital claims; 25 on practitioner claims (NCCI medically unlikely edits).
Related J02 codes
- J0200 — Injection, alatrofloxacin mesylate, 100 mg
- J0202 — Injection, alemtuzumab, 1 mg
- J0205 — Injection, alglucerase, per 10 units
- J0206 — Injection, allopurinol sodium, 1 mg
- J0207 — Injection, amifostine, 500 mg
- J0208 — Injection, sodium thiosulfate (pedmark), 100 mg
- J0209 — Injection, sodium thiosulfate (hope), 100 mg
- J0210 — Injection, methyldopate hcl, up to 250 mg
- J0211 — Injection, sodium nitrite 3 mg and sodium thiosulfate 125 mg (nithiodote)
- J0215 — Injection, alefacept, 0.5 mg
- J0216 — Injection, alfentanil hydrochloride, 500 micrograms
- J0217 — Injection, velmanase alfa-tycv, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0225
- Watch J0225 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0225
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.